Harbor Capital Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-67,282
| Closed | -$785K | – | 1493 |
|
|
2024
Q4 | $785K | Sell |
67,282
-11,923
| -15% | -$139K | 0.03% | 484 |
|
|
2024
Q3 | $1.63M | Buy |
79,205
+32,893
| +71% | +$676K | 0.07% | 360 |
|
|
2024
Q2 | $1.04M | Sell |
46,312
-4,938
| -10% | -$110K | 0.08% | 345 |
|
|
2024
Q1 | $1.41M | Buy |
51,250
+31,866
| +164% | +$877K | 0.18% | 143 |
|
|
2023
Q4 | $591K | Buy |
19,384
+2,780
| +17% | +$84.8K | 0.11% | 221 |
|
|
2023
Q3 | $525K | Buy |
16,604
+2,610
| +19% | +$82.5K | 0.11% | 218 |
|
|
2023
Q2 | $571K | Buy |
13,994
+390
| +3% | +$15.9K | 0.11% | 213 |
|
|
2023
Q1 | $507K | Buy |
13,604
+4,718
| +53% | +$176K | 0.15% | 142 |
|
|
2022
Q4 | $310K | Buy |
+8,886
| New | +$310K | 0.3% | 71 |
|